Helen I. Luikart

Summary

Helen I. Luikart. Role: ORCID lists "Research Nurse Manager" (CV Medicine, Stanford University); "Research Nurse Manager" (Cardiovascular Medicine, Stanford University). Basis of the role: ORCID employment entries without an end date (self-asserted by the record holder, may be out of date). Field indicated by the unit name: cardiology (source: the same ORCID entries). Affiliation: Stanford University, Stanford (US). Basis: ORCID record, employment entries without an end date (self-asserted, may be out of date). Counts in the OpenAlex corpus (retrieved 2026-10-10): 14 papers and 368 citations over ten years; 0 first-author and 0 last-author papers. Ranks: main 93, excluding consensus papers 80, first or last author not ranked. The method is stated once on the People list page. Linked papers are the most-cited corpus papers of this author.

Citation ranks (10 years)

Citations: 368 in total, 368 excluding consensus and guideline papers (0 of this author's papers excluded), 0 on first or last author papers (0 first, 0 last).

Role and field

Role

"Research Nurse Manager" (CV Medicine, Stanford University); "Research Nurse Manager" (Cardiovascular Medicine, Stanford University)

Role status

verified from ORCID (self-asserted entries; may be out of date)

Role basis

ORCID employment entries without an end date (self-asserted by the record holder, may be out of date)

Field

cardiology

Field basis

the same ORCID entries

Only what a cited source supports is stated. Entries marked self-asserted come from the person's own ORCID record. The field is taken from the name of the unit, not inferred from the person's name.

Details

affiliation

Stanford University, Stanford (US)

papers 10y

14

fractional papers 10y

0.91

citations 10y

368

fractional citations 10y

26.1

rising rank 5y

17 of 25

ranking retrieved

2026-10-10

orcid

0000-0002-9782-4449

openalex author id

A5071920764

merged open alex profiles

1

affiliation basis

ORCID record, employment entries without an end date (self-asserted, may be out of date)

papers excluding consensus 10y

14

citations excluding consensus 10y

368

consensus papers excluded 10y

0

first author papers 10y

0

last author papers 10y

0

lead author citations 10y

0

lead author papers 10y

0

Sources and links

• ORCID record (role and affiliation entries are self-asserted) (primary)
• OpenAlex author profile (ranking source)
• Most-cited CLAD paper in corpus: Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD) (The Journal of Heart and Lung Transplantation, 2021); 55 citations; DOI 10.1016/j.healun.2021.02.008
• Most-cited CLAD paper in corpus: Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death (American Journal of Transplantation, 2023); 27 citations; DOI 10.1016/j.ajt.2022.12.019
• Most-cited CLAD paper in corpus: Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease (The Journal of Heart and Lung Transplantation, 2024); 16 citations; DOI 10.1016/j.healun.2024.04.064
• Most-cited CLAD paper in corpus: Restrictive Allograft Syndrome Patients Have Higher Cell-Free DNA Assessed Allograft Injury Prior to Diagnosis (The Journal of Heart and Lung Transplantation, 2022); 3 citations; DOI 10.1016/j.healun.2022.01.043
• Most-cited CLAD paper in corpus: Donor-Derived-Cell-Free DNA to Identify Primary Graft Dysfunction Patients at Risk of Chronic Lung Allograft Dysfunction (The Journal of Heart and Lung Transplantation, 2020); 0 citations; DOI 10.1016/j.healun.2020.01.959
• ORCID employment entries (source of the role)

Known gaps in this record

• centre membership relation (not asserted)
• funding and conflicts of interest
• only the top-30 entries were checked by hand for ID merges and splits